142 related articles for article (PubMed ID: 12931022)
1. Expression of phosphatidylethanolamine N-methyltransferase in human hepatocellular carcinomas.
Tessitore L; Marengo B; Vance DE; Papotti M; Mussa A; Daidone MG; Costa A
Oncology; 2003; 65(2):152-8. PubMed ID: 12931022
[TBL] [Abstract][Full Text] [Related]
2. Diminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis.
Tessitore L; Dianzani I; Cui Z; Vance DE
Biochem J; 1999 Jan; 337 ( Pt 1)(Pt 1):23-7. PubMed ID: 9854020
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of phosphatidylethanolamine N-methyltransferase-2 in aflatoxin-induced liver cancer and partial reversion of the neoplastic phenotype by PEMT transfection of hepatoma cells.
Tessitore L; Sesca E; Vance DE
Int J Cancer; 2000 May; 86(3):362-7. PubMed ID: 10760824
[TBL] [Abstract][Full Text] [Related]
4. Expression of phosphatidylethanolamine N-methyltransferase in Yoshida ascites hepatoma cells and the livers of host rats.
Tessitore L; Sesca E; Bosco M; Vance DE
Carcinogenesis; 1999 Apr; 20(4):561-7. PubMed ID: 10223182
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylethanolamine N-methyltransferase from liver.
Vance DE; Walkey CJ; Cui Z
Biochim Biophys Acta; 1997 Sep; 1348(1-2):142-50. PubMed ID: 9370326
[TBL] [Abstract][Full Text] [Related]
6. Expression of phosphatidylethanolamine N-methyltransferase-2 in McArdle-RH7777 hepatoma cells inhibits the CDP-choline pathway for phosphatidylcholine biosynthesis via decreased gene expression of CTP:phosphocholine cytidylyltransferase.
Cui Z; Houweling M; Vance DE
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):939-45. PubMed ID: 8554542
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between expression of phosphatidylethanolamine N-methyltransferase-2 and growth rate of perinatal rat livers.
Cui Z; Shen YJ; Vance DE
Biochim Biophys Acta; 1997 May; 1346(1):10-6. PubMed ID: 9187297
[TBL] [Abstract][Full Text] [Related]
8. Induction of hepatocyte proliferation after partial hepatectomy is accompanied by a markedly reduced expression of phosphatidylethanolamine N-methyltransferase-2.
Houweling M; Cui Z; Tessitore L; Vance DE
Biochim Biophys Acta; 1997 May; 1346(1):1-9. PubMed ID: 9187296
[TBL] [Abstract][Full Text] [Related]
9. Transient inactivation of phosphatidylethanolamine N-methyltransferase-2 and activation of cytidine triphosphate: phosphocholine cytidylyltransferase during non-neoplastic liver growth.
Tessitore L; Cui Z; Vance DE
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):151-4. PubMed ID: 9078255
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylethanolamine N-methyltransferase: unexpected findings from curiosity-driven research.
Vance DE
Eur J Med Res; 1996 Jan; 1(4):182-8. PubMed ID: 9386267
[TBL] [Abstract][Full Text] [Related]
11. Identification of three novel cDNAs for human phosphatidylethanolamine N-methyltransferase and localization of the human gene on chromosome 17p11.2.
Walkey CJ; Shields DJ; Vance DE
Biochim Biophys Acta; 1999 Jan; 1436(3):405-12. PubMed ID: 9989271
[TBL] [Abstract][Full Text] [Related]
12. Why expression of phosphatidylethanolamine N-methyltransferase does not rescue Chinese hamster ovary cells that have an impaired CDP-choline pathway.
Waite KA; Vance DE
J Biol Chem; 2000 Jul; 275(28):21197-202. PubMed ID: 10801878
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylethanolamine methylation and hepatoma cell growth.
Vance DE; Houweling M; Lee M; Cui Z
Anticancer Res; 1996; 16(3B):1413-6. PubMed ID: 8694509
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the murine phosphatidylethanolamine N-methyltransferase-2 gene.
Walkey CJ; Cui Z; Agellon LB; Vance DE
J Lipid Res; 1996 Nov; 37(11):2341-50. PubMed ID: 8978486
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase.
Walkey CJ; Donohue LR; Bronson R; Agellon LB; Vance DE
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12880-5. PubMed ID: 9371769
[TBL] [Abstract][Full Text] [Related]
16. Predictive role BLVRA mRNA expression in hepatocellular cancer.
Kubícková KN; Subhanová I; Konícková R; Matousová L; Urbánek P; Parobková H; Kupec M; Pudil J; Vítek L
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):881-887. PubMed ID: 27740521
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of uptake mechanism of L-[methyl-(3)H]-methionine in hepatocellular carcinoma.
Kuang Y; Wang F; Corn DJ; Tian H; Lee Z
Mol Imaging Biol; 2014 Aug; 16(4):459-68. PubMed ID: 24488484
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of PEMT2 in hepatocytes initiated by DENA in fasted/refed rats.
Marengo B; Bottini C; La Porta CA; Domenicotti C; Tessitore L
Biochem Biophys Res Commun; 2006 Jul; 346(1):234-41. PubMed ID: 16756957
[TBL] [Abstract][Full Text] [Related]
19. Expression of phosphatidylethanolamine N-methyltransferase-2 is markedly enhanced in long term choline-deficient rats.
Cui Z; Vance DE
J Biol Chem; 1996 Feb; 271(5):2839-43. PubMed ID: 8576263
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
